- Home
- MQ vs HCM Comparison
MQ vs HCM Comparison
Compare MQ & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- HCM
- Stock Information
- Founded
- MQ 2010
- HCM 2000
- Country
- MQ United States
- HCM Hong Kong
- Employees
- MQ N/A
- HCM N/A
- Industry
- MQ Computer Software: Prepackaged Software
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- MQ Technology
- HCM Health Care
- Exchange
- MQ Nasdaq
- HCM Nasdaq
- Market Cap
- MQ 1.9B
- HCM 2.3B
- IPO Year
- MQ 2021
- HCM N/A
- Fundamental
- Price
- MQ $3.69
- HCM $16.11
- Analyst Decision
- MQ Hold
- HCM Hold
- Analyst Count
- MQ 15
- HCM 1
- Target Price
- MQ $5.50
- HCM $19.00
- AVG Volume (30 Days)
- MQ 4.4M
- HCM 73.5K
- Earning Date
- MQ 02-26-2025
- HCM 03-19-2025
- Dividend Yield
- MQ N/A
- HCM N/A
- EPS Growth
- MQ N/A
- HCM N/A
- EPS
- MQ 0.03
- HCM N/A
- Revenue
- MQ $490,027,000.00
- HCM $610,806,000.00
- Revenue This Year
- MQ N/A
- HCM N/A
- Revenue Next Year
- MQ $15.46
- HCM $15.89
- P/E Ratio
- MQ $137.42
- HCM N/A
- Revenue Growth
- MQ N/A
- HCM N/A
- 52 Week Low
- MQ $3.37
- HCM $12.84
- 52 Week High
- MQ $7.36
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- MQ 45.67
- HCM 68.69
- Support Level
- MQ $3.58
- HCM $13.58
- Resistance Level
- MQ $3.97
- HCM $13.96
- Average True Range (ATR)
- MQ 0.13
- HCM 0.31
- MACD
- MQ 0.00
- HCM 0.34
- Stochastic Oscillator
- MQ 29.11
- HCM 89.84
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.